APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Met-Enkephalin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Met-Enkephalin Market Outlook and Growth Opportunities 2026

Report ID 174012380430 December 2025192 pages

Choose your research edition.

Industry ResearchMet-Enkephalin Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Met-Enkephalin Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Met-Enkephalin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Met-Enkephalin Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Met-Enkephalin Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Met-Enkephalin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Met-Enkephalin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Met-Enkephalin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Met-Enkephalin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Met-Enkephalin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Met-Enkephalin market include Thermo Scientific, Neuromics, Genscript, Cayman Chemical, Bachem, Abcam, Abbiotec and Aapptec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Met-Enkephalin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Met-Enkephalin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Met-Enkephalin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Met-Enkephalin market size, projected growth trends, production technologies, key applications, and end-use industries.

Met-Enkephalin Segment by Company

Thermo Scientific

Neuromics

Genscript

Cayman Chemical

Bachem

Abcam

Abbiotec

Aapptec

Met-Enkephalin Segment by Type

Mouse

Rabbit

Human

Rat

Met-Enkephalin Segment by Application

Scientific Research

Medical

Others

Met-Enkephalin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Met-Enkephalin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Met-Enkephalin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Met-Enkephalin significant trends, drivers, influence factors in global and regions.

6. To analyze Met-Enkephalin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Met-Enkephalin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Met-Enkephalin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Met-Enkephalin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Met-Enkephalin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Met-Enkephalin industry.

Chapter 3: Detailed analysis of Met-Enkephalin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Met-Enkephalin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Met-Enkephalin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Met-Enkephalin Industry Trends Table 2. Met-Enkephalin Industry Drivers Table 3. Met-Enkephalin Industry Opportunities and Challenges Table 4. Met-Enkephalin Industry Restraints Table 5. Global Met-Enkephalin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Met-Enkephalin Revenue Share by Company (2021-2026) Table 7. Global Met-Enkephalin Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Met-Enkephalin Sales Volume Share by Company (2021-2026) Table 9. Global Met-Enkephalin Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Met-Enkephalin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Met-Enkephalin Key Company Manufacturing Base & Headquarters Table 12. Global Met-Enkephalin Company, Product Type & Application Table 13. Global Met-Enkephalin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Met-Enkephalin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Mouse Table 18. Significant Companies of Rabbit Table 19. Significant Companies of Human Table 20. Significant Companies of Rat Table 21. Global Met-Enkephalin Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Met-Enkephalin Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Met-Enkephalin Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Met-Enkephalin Sales Volume Share by Type (2021-2026) Table 25. Global Met-Enkephalin Sales Volume Share by Type (2027-2032) Table 26. Global Met-Enkephalin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Met-Enkephalin Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Met-Enkephalin Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Met-Enkephalin Sales Value Share by Type (2021-2026) Table 30. Global Met-Enkephalin Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Scientific Research Table 32. Significant Companies of Medical Table 33. Significant Companies of Others Table 34. Global Met-Enkephalin Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Met-Enkephalin Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Met-Enkephalin Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Met-Enkephalin Sales Volume Share by Application (2021-2026) Table 38. Global Met-Enkephalin Sales Volume Share by Application (2027-2032) Table 39. Global Met-Enkephalin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Met-Enkephalin Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Met-Enkephalin Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Met-Enkephalin Sales Value Share by Application (2021-2026) Table 43. Global Met-Enkephalin Sales Value Share by Application (2027-2032) Table 44. Global Met-Enkephalin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Met-Enkephalin Sales by Region (2021-2026) & (K Units) Table 46. Global Met-Enkephalin Sales Market Share by Region (2021-2026) Table 47. Global Met-Enkephalin Sales by Region (2027-2032) & (K Units) Table 48. Global Met-Enkephalin Sales Market Share by Region (2027-2032) Table 49. Global Met-Enkephalin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Met-Enkephalin Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Met-Enkephalin Sales Value Share by Region (2021-2026) Table 52. Global Met-Enkephalin Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Met-Enkephalin Sales Value Share by Region (2027-2032) Table 54. Global Met-Enkephalin Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Met-Enkephalin Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Met-Enkephalin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Met-Enkephalin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Met-Enkephalin Sales by Country (2021-2026) & (K Units) Table 59. Global Met-Enkephalin Sales Market Share by Country (2021-2026) Table 60. Global Met-Enkephalin Sales by Country (2027-2032) & (K Units) Table 61. Global Met-Enkephalin Sales Market Share by Country (2027-2032) Table 62. Global Met-Enkephalin Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Met-Enkephalin Sales Value Market Share by Country (2021-2026) Table 64. Global Met-Enkephalin Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Met-Enkephalin Sales Value Market Share by Country (2027-2032) Table 66. Thermo Scientific Company Information Table 67. Thermo Scientific Business Overview Table 68. Thermo Scientific Met-Enkephalin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Thermo Scientific Met-Enkephalin Product Portfolio Table 70. Thermo Scientific Recent Development Table 71. Neuromics Company Information Table 72. Neuromics Business Overview Table 73. Neuromics Met-Enkephalin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Neuromics Met-Enkephalin Product Portfolio Table 75. Neuromics Recent Development Table 76. Genscript Company Information Table 77. Genscript Business Overview Table 78. Genscript Met-Enkephalin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Genscript Met-Enkephalin Product Portfolio Table 80. Genscript Recent Development Table 81. Cayman Chemical Company Information Table 82. Cayman Chemical Business Overview Table 83. Cayman Chemical Met-Enkephalin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Cayman Chemical Met-Enkephalin Product Portfolio Table 85. Cayman Chemical Recent Development Table 86. Bachem Company Information Table 87. Bachem Business Overview Table 88. Bachem Met-Enkephalin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Bachem Met-Enkephalin Product Portfolio Table 90. Bachem Recent Development Table 91. Abcam Company Information Table 92. Abcam Business Overview Table 93. Abcam Met-Enkephalin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Abcam Met-Enkephalin Product Portfolio Table 95. Abcam Recent Development Table 96. Abbiotec Company Information Table 97. Abbiotec Business Overview Table 98. Abbiotec Met-Enkephalin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Abbiotec Met-Enkephalin Product Portfolio Table 100. Abbiotec Recent Development Table 101. Aapptec Company Information Table 102. Aapptec Business Overview Table 103. Aapptec Met-Enkephalin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Aapptec Met-Enkephalin Product Portfolio Table 105. Aapptec Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Met-Enkephalin Distributors List Table 109. Met-Enkephalin Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Met-Enkephalin Product Image Figure 2. Global Met-Enkephalin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Met-Enkephalin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Met-Enkephalin Sales (2021-2032) & (K Units) Figure 5. Global Met-Enkephalin Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Met-Enkephalin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Mouse Image Figure 10. Rabbit Image Figure 11. Human Image Figure 12. Rat Image Figure 13. Global Met-Enkephalin Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Met-Enkephalin Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Met-Enkephalin Sales Volume Share by Type (2021-2032) Figure 16. Global Met-Enkephalin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Met-Enkephalin Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Met-Enkephalin Sales Value Share by Type (2021-2032) Figure 19. Scientific Research Image Figure 20. Medical Image Figure 21. Others Image Figure 22. Global Met-Enkephalin Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Met-Enkephalin Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Met-Enkephalin Sales Volume Share by Application (2021-2032) Figure 25. Global Met-Enkephalin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Met-Enkephalin Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Met-Enkephalin Sales Value Share by Application (2021-2032) Figure 28. Global Met-Enkephalin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Met-Enkephalin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Met-Enkephalin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Met-Enkephalin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Met-Enkephalin Sales Value (2021-2032) & (US$ Million) Figure 33. North America Met-Enkephalin Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Met-Enkephalin Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Met-Enkephalin Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Met-Enkephalin Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Met-Enkephalin Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Met-Enkephalin Sales Value (2021-2032) & (US$ Million) Figure 39. South America Met-Enkephalin Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Met-Enkephalin Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Met-Enkephalin Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Met-Enkephalin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Met-Enkephalin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Met-Enkephalin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Met-Enkephalin Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Met-Enkephalin Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Mouse
  • Rabbit
  • Human
  • Rat
Applications
  • Scientific Research
  • Medical
  • Others
Companies covered
  • Thermo Scientific
  • Neuromics
  • Genscript
  • Cayman Chemical
  • Bachem
  • Abcam
  • Abbiotec
  • Aapptec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Met-Enkephalin Sales Value (2021-2032)
  4. 1.2.2 Global Met-Enkephalin Sales Volume (2021-2032)
  5. 1.2.3 Global Met-Enkephalin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Met-Enkephalin Market Dynamics
  1. 2.1 Met-Enkephalin Industry Trends
  2. 2.2 Met-Enkephalin Industry Drivers
  3. 2.3 Met-Enkephalin Industry Opportunities and Challenges
  4. 2.4 Met-Enkephalin Industry Restraints
3 Met-Enkephalin Market by Company
  1. 3.1 Global Met-Enkephalin Company Revenue Ranking in 2025
  2. 3.2 Global Met-Enkephalin Revenue by Company (2021-2026)
  3. 3.3 Global Met-Enkephalin Sales Volume by Company (2021-2026)
  4. 3.4 Global Met-Enkephalin Average Price by Company (2021-2026)
  5. 3.5 Global Met-Enkephalin Company Ranking (2024-2026)
  6. 3.6 Global Met-Enkephalin Company Manufacturing Base and Headquarters
  7. 3.7 Global Met-Enkephalin Company Product Type and Application
  8. 3.8 Global Met-Enkephalin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Met-Enkephalin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Met-Enkephalin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Met-Enkephalin Market by Type
  1. 4.1 Met-Enkephalin Type Introduction
  2. 4.1.1 Mouse
  3. 4.1.2 Rabbit
  4. 4.1.3 Human
  5. 4.1.4 Rat
  6. 4.2 Global Met-Enkephalin Sales Volume by Type
  7. 4.2.1 Global Met-Enkephalin Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Met-Enkephalin Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Met-Enkephalin Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Met-Enkephalin Sales Value by Type
  11. 4.3.1 Global Met-Enkephalin Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Met-Enkephalin Sales Value by Type (2021-2032)
  13. 4.3.3 Global Met-Enkephalin Sales Value Share by Type (2021-2032)
5 Met-Enkephalin Market by Application
  1. 5.1 Met-Enkephalin Application Introduction
  2. 5.1.1 Scientific Research
  3. 5.1.2 Medical
  4. 5.1.3 Others
  5. 5.2 Global Met-Enkephalin Sales Volume by Application
  6. 5.2.1 Global Met-Enkephalin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Met-Enkephalin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Met-Enkephalin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Met-Enkephalin Sales Value by Application
  10. 5.3.1 Global Met-Enkephalin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Met-Enkephalin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Met-Enkephalin Sales Value Share by Application (2021-2032)
6 Met-Enkephalin Regional Sales and Value Analysis
  1. 6.1 Global Met-Enkephalin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Met-Enkephalin Sales by Region (2021-2032)
  3. 6.2.1 Global Met-Enkephalin Sales by Region: 2021-2026
  4. 6.2.2 Global Met-Enkephalin Sales by Region (2027-2032)
  5. 6.3 Global Met-Enkephalin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Met-Enkephalin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Met-Enkephalin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Met-Enkephalin Sales Value by Region (2027-2032)
  9. 6.5 Global Met-Enkephalin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Met-Enkephalin Sales Value (2021-2032)
  12. 6.6.2 North America Met-Enkephalin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Met-Enkephalin Sales Value (2021-2032)
  15. 6.7.2 Europe Met-Enkephalin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Met-Enkephalin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Met-Enkephalin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Met-Enkephalin Sales Value (2021-2032)
  21. 6.9.2 South America Met-Enkephalin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Met-Enkephalin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Met-Enkephalin Sales Value Share by Country, 2025 VS 2032
7 Met-Enkephalin Country-level Sales and Value Analysis
  1. 7.1 Global Met-Enkephalin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Met-Enkephalin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Met-Enkephalin Sales by Country (2021-2032)
  4. 7.3.1 Global Met-Enkephalin Sales by Country (2021-2026)
  5. 7.3.2 Global Met-Enkephalin Sales by Country (2027-2032)
  6. 7.4 Global Met-Enkephalin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Met-Enkephalin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Met-Enkephalin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Met-Enkephalin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Met-Enkephalin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Met-Enkephalin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Met-Enkephalin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Met-Enkephalin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Met-Enkephalin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Met-Enkephalin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Met-Enkephalin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Met-Enkephalin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Met-Enkephalin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Met-Enkephalin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Met-Enkephalin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Met-Enkephalin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Met-Enkephalin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Met-Enkephalin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Met-Enkephalin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Met-Enkephalin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Met-Enkephalin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Met-Enkephalin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Met-Enkephalin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Met-Enkephalin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Met-Enkephalin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Met-Enkephalin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Met-Enkephalin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Met-Enkephalin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Met-Enkephalin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Met-Enkephalin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Met-Enkephalin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Met-Enkephalin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Met-Enkephalin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Scientific
  2. 8.1.1 Thermo Scientific Company Information
  3. 8.1.2 Thermo Scientific Business Overview
  4. 8.1.3 Thermo Scientific Met-Enkephalin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Scientific Met-Enkephalin Product Portfolio
  6. 8.1.5 Thermo Scientific Recent Developments
  7. 8.2 Neuromics
  8. 8.2.1 Neuromics Company Information
  9. 8.2.2 Neuromics Business Overview
  10. 8.2.3 Neuromics Met-Enkephalin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Neuromics Met-Enkephalin Product Portfolio
  12. 8.2.5 Neuromics Recent Developments
  13. 8.3 Genscript
  14. 8.3.1 Genscript Company Information
  15. 8.3.2 Genscript Business Overview
  16. 8.3.3 Genscript Met-Enkephalin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Genscript Met-Enkephalin Product Portfolio
  18. 8.3.5 Genscript Recent Developments
  19. 8.4 Cayman Chemical
  20. 8.4.1 Cayman Chemical Company Information
  21. 8.4.2 Cayman Chemical Business Overview
  22. 8.4.3 Cayman Chemical Met-Enkephalin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Cayman Chemical Met-Enkephalin Product Portfolio
  24. 8.4.5 Cayman Chemical Recent Developments
  25. 8.5 Bachem
  26. 8.5.1 Bachem Company Information
  27. 8.5.2 Bachem Business Overview
  28. 8.5.3 Bachem Met-Enkephalin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Bachem Met-Enkephalin Product Portfolio
  30. 8.5.5 Bachem Recent Developments
  31. 8.6 Abcam
  32. 8.6.1 Abcam Company Information
  33. 8.6.2 Abcam Business Overview
  34. 8.6.3 Abcam Met-Enkephalin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Abcam Met-Enkephalin Product Portfolio
  36. 8.6.5 Abcam Recent Developments
  37. 8.7 Abbiotec
  38. 8.7.1 Abbiotec Company Information
  39. 8.7.2 Abbiotec Business Overview
  40. 8.7.3 Abbiotec Met-Enkephalin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Abbiotec Met-Enkephalin Product Portfolio
  42. 8.7.5 Abbiotec Recent Developments
  43. 8.8 Aapptec
  44. 8.8.1 Aapptec Company Information
  45. 8.8.2 Aapptec Business Overview
  46. 8.8.3 Aapptec Met-Enkephalin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Aapptec Met-Enkephalin Product Portfolio
  48. 8.8.5 Aapptec Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Met-Enkephalin Value Chain Analysis
  2. 9.1.1 Met-Enkephalin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Met-Enkephalin Sales Mode & Process
  6. 9.2 Met-Enkephalin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Met-Enkephalin Distributors
  9. 9.2.3 Met-Enkephalin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst